Ureteral Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global ureteral stents market size reached US$ 332.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 480.3 Million by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Ureteral stents are thin tubes placed in the ureter to help drain urine from the kidney. Their top portion sits on the kidney and the opposite end curls around the bladder. They are primarily utilized to let urine flow through the blocked ureter, decrease the pain associated with the blockage, allow the kidney to function normally and keep the ureter open. They assist in treating and managing conditions like kidney stones, kidney transplants and urinary incontinence. Besides this, they are also used during the treatment of prostate cancer and tumors across the globe.
The rising incidences of kidney and ureteral stones on account of the increasing number of individuals that smoke and consume alcohol represents one of the key factors driving the ureteral stents market. Ureteral stents play a vital role in the procedure of ureteroscopy and ureterorenoscopy. Moreover, during kidney transplants, they are placed in the body of the patient for a few days until the newly implanted kidney adapts to the body. Apart from this, the growing number of renal transplants and rising concerns related to renal dysfunction have also fueled the need for ureteral stents around the world. Furthermore, technological developments in ureteral stents, including the usage of biodegradable materials, have resulted in efficient and improved outcomes concerning urinary and kidney disorders. Moreover, the key players are focusing on reducing stent migration, ureterovesical reflux and tissue irritation during the procedure, which is anticipated to strengthen the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ureteral stents market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, material, application and end use.
Breakup by Product Type:
Open End Stents
Closed End Stents
Double J-Stent
Multiloop Stents
Breakup by Material:
Metallic Ureteral Stents
Polymer Ureteral Stents
Silicone Stents
Polyurethane Stents
Hybrid Stents
Breakup by Application:
Kidney Stones
Kidney Transplantation
Tumors
Urinary Incontinence
Others
Breakup by End Use:
Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allium Medical Solutions Ltd., B. Braun Melsungen AG, Biomerics, Boston Scientific Corporation, Becton, Dickinson and Company, Coloplast Ltd., Cook Group Incorporated, Medline Industries Inc., Merit Medical Systems Inc., Olympus Corporation and Teleflex Incorporated.
Key Questions Answered in This Report
1. What was the size of the global ureteral stents market in 2021?
2. What is the expected growth rate of the global ureteral stents market during 2022-2027?
3. What has been the impact of COVID-19 on the global ureteral stents market?
4. What are the key factors driving the global ureteral stents market?
5. What is the breakup of the global ureteral stents market based on the product type?
6. What is the breakup of the global ureteral stents market based on the material?
7. What is the breakup of the global ureteral stents market based on the application?
8. What is the breakup of the global ureteral stents market based on the end use?
9. What are the key regions in the global ureteral stents market?
10. Who are the key players/companies in the global ureteral stents market?
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Ureteral Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product Type
- 6.1 Open End Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Closed End Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Double J-Stents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Multiloop Stents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 7 Market Breakup by Material
- 7.1 Metallic Ureteral Stents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Polymer Ureteral Stents
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Silicone Stents
- 7.2.2.2 Polyurethane Stents
- 7.2.2.3 Hybrid Stents
- 7.2.3 Market Forecast
- 8 Market Breakup by Application
- 8.1 Kidney Stones
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Kidney Transplantation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Tumors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Urinary Incontinence
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 9 Market Breakup by End Use
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgical Centers (ASCs)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
- 11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
- 12 Value Chain Analysis
- 13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
- 14 Price Analysis
- 15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Allium Medical Solutions Ltd.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.2 B. Braun Melsungen AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 SWOT Analysis
- 15.3.3 Biomerics
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Boston Scientific Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Becton Dickinson and Company
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Coloplast Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Cook Group Incorporated
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Medline Industries Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 SWOT Analysis
- 15.3.9 Merit Medical Systems Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Olympus Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Teleflex Incorporated
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook